Aberrant methylation of the HIC1 promoter is a frequent event in specific pediatric neoplasms

Clinical Cancer Research

Volumn 9, Issue 10 I, 2003, Pages 3674-3678

  Rathi, Asha ^a   Virmani, Arvind K ^a,b   Harada, Kenichi ^a   Timmons, Charles F ^c   Miyajima, Kuniharu ^a   Hay, Robert J ^e   Mastrangelo, Domenico ^d   Maitra, Anirban ^b   Tomlinson, Gail E ^a,b   Gazdar, Adi F ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c CHILDREN S MEDICAL CENTER   (United States)

^d UNIVERSITY OF SIENA   (Italy)

^e AMERICAN TYPE CULTURE COLLECTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE;

ARTICLE; CANCER CELL CULTURE; CHILD; CHILDHOOD CANCER; CHROMOSOME 17P; CONTROLLED STUDY; DNA METHYLATION; DNA SEQUENCE; EWING SARCOMA; GANGLIONEUROMA; GENE; GERM CELL TUMOR; HEPATOBLASTOMA; HIC1 GENE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MEDULLOBLASTOMA; NEPHROBLASTOMA; NEUROBLASTIC TUMOR; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; OSTEOSARCOMA; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; RETINOBLASTOMA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOMYOSARCOMA; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; CELL LINE, TUMOR; CHILD; CHILD, PRESCHOOL; DNA METHYLATION; HUMANS; INFANT; NEOPLASMS; PROMOTER REGIONS (GENETICS); REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION FACTORS;

EID: 12444250673     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Esteller, M., and Herman, J. G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol., 196: 1-7, 2002.
2. Wales, M. M., Biel, M. A., el Deiry, W., Nelkin, B. D., Issa, J. P., Cavenee, W. K., Kuerbitz, S. J., and Baylin, S. B. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med., 1: 570-577, 1995.
3. Eiriksdottir, G., Barkardottir, R. B., Agnarsson, B. A., Johannesdottir, G., Olafsdottir, K., Egilsson, V., and Ingvarsson, S. High incidence of loss of heterozygosity at chromosome 17p13 in breast tumours from BRCA2 mutation carriers. Oncogene, 16: 21-26, 1998.
4. Phillips, N., Ziegler, M., Saha, B., and Xynos, F. Allelic loss on chromosome 17 in human ovarian cancer. Int. J. Cancer, 54: 85-91, 1993.
5. Konishi, H., Takahashi, T., Kozaki, K., Yatabe, Y., Mitsudomi, T., Fujii, Y., Sugiura, T., and Matsuda, H. Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene, 17: 2095-2100, 1998.
6. Makos, M., Nelkin, B. D., Lerman, M. I., Latif, F., Zbar, B., and Baylin, S. B. Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. Proc. Natl. Acad. Sci. USA, 89: 1929-1933, 1992.
7. Eguchi, K., Kanai, Y., Kobayashi, K., and Hirohashi, S. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history. Cancer Res., 57: 4913-4915, 1997.
8. Fujii, H., Biel, M. A., Zhou, W., Weitzman, S. A., Baylin, S. B., and Gabrielson, E. Methylation of the HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene, 16: 2159-2164, 1998.
9. Li, Q., Jedlicka, A., Ahuja, N., Gibbons, M. C., Baylin, S. B., Burger, P. C., and Issa, J. P. Concordant methylation of the ER and N33 genes in glioblastoma multiforme. Oncogene, 16: 3197-3202, 1998.
10. Makos, M., Nelkin, B. D., Reiter, R. E., Gnarra, J. R., Brooks, J., Isaacs, W., Linehan, M., and Baylin, S. B. Regional DNA hypermethylation at D17S5 precedes 17p structural changes in the progression of renal tumors. Cancer Res., 53: 2719-2722, 1993.
11. Kanai, Y., Hui, A. M., Sun, L., Ushijima, S., Sakamoto, M., Tsuda, H., and Hirohashi, S. DNA hypermethylation at the D17S5 locus and reduced HIC-1 mRNA expression are associated with hepatocarcinogenesis. Hepatology, 29: 703-709, 1999.
12. Dong, S. M., Kim, H. S., Rha, S. H., and Sidransky, D. Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix. Clin. Cancer Res., 7: 1982-1986, 2001.
13. Strathdee, G., Appleton, K., Illand, M., Millan, D. W., Sargent, J., Paul, J., and Brown, R. Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes. Am. J. Pathol., 158: 1121-1127, 2001.
14. Rathi, A., Virmani, A. K., Schorge, J. O., Elias, K. J., Maruyama, R., Minna, J. D., Mok, S. C., Girard, L., Fishman, D. A., and Gazdar, A. F. Methylation profiles of sporadic ovarian tumors and nonmalignant ovaries from high-risk women. Clin. Cancer Res., 8: 3324-3331, 2002.
15. Issa, J. P., Zehnbauer, B. A., Kaufmann, S. H., Biel, M. A., and Baylin, S. B. HIC1 hypermethylation is a late event in hematopoietic neoplasms. Cancer Res., 57: 1678-1681, 1997.
16. Rood, B. R., Zhang, H., Weitman, D. M., and Cogen, P. H. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res., 62: 3794-3797, 2002.
17. Herman, J. G., Civin, C. I., Issa, J. P., Collector, M. I., Sharkis, S. J., and Baylin, S. B. Distinct patterns of inactivation of p15INK4B and p16INK4A characterize the major types of hematological malignancies. Cancer Res., 57: 837-841, 1997.
18. Chen, X. Q., Bonnefoi, H., Pelte, M. F., Lyautey, J., Lederrey, C., Movarekhi, S., Schaeffer, P., Mulcahy, H. E., Meyer, P., Stroun, M., and Anker, P. Telomerase RNA as a detection marker in the serum of breast cancer patients. Clin. Cancer Res., 6: 3823-3826, 2000.
19. Harada, K., Toyooka, S., Maitra, A., Maruyama, R., Toyooka, K. O., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., Hay, R. J., Minna, J. D., and Gazdar, A. F. Aberrant promoter methylation and silencing of the RASSFIA gene in pediatric tumors and cell lines. Oncogene, 21: 4345-4349, 2002.
20. Harada, K., Toyooka, S., Shivapurkar, N., Maitra, A., Reddy, J. L., Matta, H., Miyajima, K., Timmons, C. F., Tomlinson, G. E., Mastrangelo, D., Hay, R. J., Chaudhary, P. M., and Gazdar, A. F. Deregulation of caspase 8 and 10 expression in pediatric tumors and cell lines. Cancer Res., 62: 5897-5901, 2002.
21. van Noesel, M. M., van Bezouw, S., Salomons, G. S., Voute, P. A., Pieters, R., Baylin, S. B., Herman, J. G., and Versteeg, R. Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. Cancer Res., 62: 2157-2161, 2002.
22. Guerardel, C., Deltour, S., Pinte, S., Monte, D., Begue, A., Godwin, A. K., and Leprince, D. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem., 276: 3078-3089, 2001.
23. Chen, W. Y., Zeng, X., Carter, M. G., Morrell, C. N., Chiu Yen, R. W., Esteller, M., Watkins, D. N., Herman, J. G., Mankowski, J. L., and Baylin, S. B. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet., 33: 197-202, 2003.
24. Nicoll, G., Crichton, D. N., McDowell, H. E., Kernohan, N., Hupp, T. R., and Thompson, A. M. Expression of the hypermethylated in cancer gene (HIC-1) is associated with good outcome in human breast cancer. Br. J. Cancer, 85: 1878-1882, 2001.
25. Hayashi, M., Tokuchi, Y., Hashimoto, T., Hayashi, S., Nishida, K., Ishikawa, Y., Nakagawa, K., Tsuchiya, S., Okumura, S., and Tsuchiya, E. Reduced HIC-1 gene expression in non-small cell lung cancer and its clinical significance. Anticancer Res., 21: 535-540, 2001.
26. Knudson, A. G. Two genetic hits (more or less) to cancer. Nat. Rev. Cancer, 1: 157-162, 2001.